Galectin7 attenuates abdominal aortic aneurysm progression by resisting disturbed flow induced endothelial-to-mesenchymal transition
Abstract
EndMT transformation in ECs exposed to d-flow was the critical driver of AAA development. Furthermore, endothelium-enriched galectin-7 suppressed the EndMT process induced by d-flow and prevent AAA progression by transcriptionally inhibiting SRGN via competitive binding with CREB to restrict TGFβ/smad pathway.
Fields of Study & Subjects
Aortic aneurysm repair treatments
Galectins and Cancer Biology
IL-33
ST2
and ILC Pathways
Publication details
- Journal / source
- Theranostics
- Publisher
- Ivyspring International Publisher
- Volume
- 16
- Issue
- 7
- Pages
- 3665–3684
- Publication date
- 8 January 2026
- Language
- EN